Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
about
A mitochondrial pathway for biosynthesis of lipid mediatorsExpression of calreticulin is associated with infiltration of T-cells in stage IIIB colon cancerA novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell deathAdvances in targeted and immunobased therapies for colorectal cancer in the genomic eraImmunological aspects of antitumor photodynamic therapy outcomePotential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?Necroptotic Cell Death Signaling and Execution Pathway: Lessons from Knockout MiceTargeting Epigenetic Processes in Photodynamic Therapy-Induced Anticancer ImmunityClinical significance of procoagulant microparticlesBiomarkers and molecular probes for cell death imaging and targeted therapeuticsImmune escape mechanisms in colorectal cancer pathogenesis and liver metastasisTrial Watch: Immunogenic cell death inducers for anticancer chemotherapyPhotodynamic therapy induces an immune response against a bacterial pathogenCell death-associated molecular-pattern molecules: inflammatory signaling and controlT-cell mediated anti-tumor immunity after photodynamic therapy: why does it not always work and how can we improve it?The Impact of Chemotherapy, Radiation and Epigenetic Modifiers in Cancer Cell Expression of Immune Inhibitory and Stimulatory Molecules and Anti-Tumor EfficacyAutophagy-Dependent Secretion: Contribution to Tumor ProgressionTumor cell lysates as immunogenic sources for cancer vaccine designRose Bengal acetate photodynamic therapy (RBAc-PDT) induces exposure and release of Damage-Associated Molecular Patterns (DAMPs) in human HeLa cellsAlcoholism and inflammation: neuroimmunology of behavioral and mood disordersImmunogenic versus tolerogenic phagocytosis during anticancer therapy: mechanisms and clinical translationTrailing TRAIL Resistance: Novel Targets for TRAIL Sensitization in Cancer CellsGinsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulationThe Roles of Mitochondrial Damage-Associated Molecular Patterns in DiseasesPrimary effusion lymphoma cell death induced by bortezomib and AG 490 activates dendritic cells through CD91In vitro studies on erythrosine-based photodynamic therapy of malignant and pre-malignant oral epithelial cellsHigh mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependenceDangers within: DAMP responses to damage and cell death in kidney disease.Cerebrospinal fluid mitochondrial DNA: a novel DAMP in pediatric traumatic brain injuryCeramide and sphingosine-1-phosphate act as photodynamic therapy-elicited damage-associated molecular patterns: cell surface exposureNew frontiers in the treatment of colorectal cancer: Autophagy and the unfolded protein response as promising targetsPhytochemicals Approach for Developing Cancer Immunotherapeutics.In vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancerResolution of Cochlear Inflammation: Novel Target for Preventing or Ameliorating Drug-, Noise- and Age-related Hearing Loss.Antitumor immunity induced after α irradiationPoly(I:C) enhances the susceptibility of leukemic cells to NK cell cytotoxicity and phagocytosis by DCAntitumor immunologically modified carbon nanotubes for photothermal therapy.SHARPIN is essential for cytokine production, NF-κB signaling, and induction of Th1 differentiation by dendritic cells.ATP release from dying autophagic cells and their phagocytosis are crucial for inflammasome activation in macrophagesEndoplasmic reticulum stress and cancer.
P2860
Q23924138-C9304B8B-451E-4EC5-9BCA-802399240916Q24609433-5EACF644-1ECD-411A-A5A1-57D449DD4FA8Q24620548-1B347F4B-1682-453B-BB53-A26FC94AAF7CQ26751344-C04F6E1D-971C-4CA6-97FE-AEB5CA55CFF0Q26767138-E67FA1A7-E13B-4A50-B411-FECC5E02C359Q26771601-EB73E9C7-6A0E-4D5A-82ED-2BEEA3A4A662Q26778547-89D85FD4-11D9-408A-A657-7A153883203BQ26797280-16D162C3-D113-4B54-9FC9-9CB50D4D3FFCQ26830846-4E5414A3-65C9-4554-94C0-14EBA22B12E2Q26866387-9513E950-F01A-4F9E-8622-43D44C5D7F39Q27002388-34633507-23A4-4949-AEDE-E654CADFF807Q27004011-C929EFD2-1AEF-4BC5-8AEF-9D605EA8C9BBQ27013274-19061F20-BAFC-4E37-985D-0017034028BFQ27014671-621C8486-35EB-4B0A-B0E0-9FC46B709958Q27335110-BF2ACEA0-3C35-4D4C-B75D-2202DBD277E1Q28076473-2D0B2101-0DCE-47A9-8F34-0C680EA15FEFQ28078649-B750AD1D-23DC-41DD-A872-E05FC2F3B1A6Q28083469-47BED5C1-1716-4FF3-A8F1-053908F10106Q28246367-55244AD7-8871-4AB3-AB98-BB1C4F1192E9Q28302013-41E2C765-5FD7-40BF-B740-54F684344F3CQ28386858-16561E3A-BB1F-4959-AE70-16A3E90F6CD7Q28391040-88222137-20D2-4D6A-83D4-7E0369F5CA02Q28394059-BAB88135-BA36-4707-84BF-4C584CAA1B94Q28396823-DE2432FC-A5AE-42EC-98F3-35A9358CE43DQ28481417-28D78747-F8E7-437C-8506-5F2FE6736A24Q28482082-EA00C3AB-614C-4E8F-9730-764309F764F3Q28568437-C5912700-8A8A-4E5D-8008-56CA02E49CA5Q30380000-EE3EB9A8-9F95-4E38-B5EE-40E189AA94D9Q33625095-1ECBCD63-6E66-4ABC-9440-1C247D2DB60AQ33705468-1846E1E9-BD1F-4CF3-BF2D-4E30723F6621Q33731804-AC0C3971-291C-4E6D-9D89-10AB59EA5AB0Q33809573-9561F653-D7D9-4F0C-8312-06D8A8E1131FQ33849055-B6BE592A-36D3-41EA-9745-5489AA4E1F05Q33882297-DF49D112-AA66-46CB-9190-2BBAF9921821Q33891246-2984AABA-E843-4BA1-B3A1-D053D886EF29Q33940675-90276D62-6FB3-42A6-A03E-914DB9354BFDQ34148210-3075D5A8-9813-4699-A17A-B57250199A44Q34163726-03B35BD5-B17A-47BB-9189-9604FED2E00AQ34328636-E4BFA147-E0DB-4A84-9AF8-0C80B87610C5Q34376123-DB3EF536-6E31-44E0-93FB-0AEA8FA702B8
P2860
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@ast
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@en
type
label
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@ast
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@en
prefLabel
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@ast
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@en
P50
P1476
Immunogenic cell death, DAMPs and anticancer therapeutics: an emerging amalgamation.
@en
P356
10.1016/J.BBCAN.2009.08.003
P407
P577
2009-08-28T00:00:00Z